expect mix us stapl trend poor
momentum across sector improv sequenti gross
margin perform moder commod pressur
preview ep preview highlight tactic opportun
head earn ow rate long-term expect biggest
focu ep result around sustain recent top-line
growth pickup price momentum believ durabl longer-
term beverag rel hpc/food greater price power retail
perspect divers channel mix tilt balanc power beverag
compani consum perspect lower privat label penetr
competit perspect concentr market share beverag
compani said short-term unfavor us extent europ
weather limit beverag top-line result view temporari
phenomenon note favor weather far
short-term trade opportun believ best short-term trade
quarter long pg/kmb expect top-line upsid expect ep
guidanc rais cautiou top-line soft risk
consensu estim initi guidanc call
becom consensu still believ make sens tactic head
procter gambl pg expect continu strong top-line growth
probabl even rang inflect margin expans
expect ep upsid rais ep
guidanc lower commod inflat net
assum reinvest neg side expect
neg stock reaction disappoint initi guidanc ep
growth estim bp consensu expect benefit
price dissip increas trade invest along
ko remain top us stapl pick expect mute poor
weather us lesser extent europ ko remain top
stapl pick market give ko credit superior top-line growth
outlook stronger price power favor strategi tweak rebound
emerg market trend well potenti ep inflect non-
oper unfavor item dissip improv convers
alreadi guid weak detail ow thesi ko pleas see
recent may upgrad note thing upgrad ow structur higher
growth reflect valuat video webcast replay
slide deck
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
pg/pep/el ow idea believ ko stand top ow pick
also ow pg/pep/el order although acknowledg strong ytd
stock out-performance name limit extent upsid procter
gambl pg see sustain high qualiti top-line improv strong
breadth across portfolio pg market share rebound despit pullback
promot vs peer combin inflect gross margin
price build commod moder drive stock out-performance
pepsi-cola post solid see note see continu solid organ
sale growth albeit deceler difficult comparison gm
expans robust price strong ep visibl re-bas
new ceo lauder el believ market undervalu
est lt growth potenti favor exposur high growth
channels/geographi within high growth prestig beauti categori
near-term ep upsid albeit less stock upsid given el valuat premium
/kdp top uw idea see risk stretch
valuat key area risk expect consensu ep
guidanc anticip outsiz gross margin expans
emerg competit threat glad trash bag clorox disinfect wipe
charcoal like linger trade line peer
believ market overestim lt growth potenti
limit revenu growth ebitda margin expans synergy-rel
growth dissip next coupl year near-term risk base
slow us coffe pod scanner data result recent alphawis
survey consum also believ market appropri
factor high risk level larg deal recent dp high debt
leverag aggress assumpt full drop-through cost synergi
bottom line top base busi growth given opaqu coffe
exhibit ep ms estim chang current quarter current fy
estim ccep
tabl content
beverag household product packag food
mute stock reaction quarter still top us stapl pick expect
mute stock reaction ko result expect softer
prior four quarter given unfavor weather us/europ confirm
scanner data trend despit expect mute ko remain top us stapl
pick believ market look past near-term weather-induc weak
focu solid fy lt top-line outlook eps/fcf growth inflect
beyond detail ow thesi ko pleas see
recent webcast replay dial id
slide show upgrad note video
note post call ko cfo
softer organ sale growth forecast underli organ sale
growth unit case volum growth price/mix base unit case
volum growth price/mix recent lower organ sale growth
note reflect weaker scanner data north
america/europ poor weather averag basi forecast organ
sale growth vs adjust point benefit
brexit-rel inventori build
slower scanner data growth us/western europ ko us sale growth
y-o-i average
yr average average due poor weather particularli may
y-o-i european scanner data sale growth also slow less
favor weather ko sale y-o-i
average versu average average
expect unchang organ top-line ep guidanc believ ko
reiter full-year guidanc includ organ sale growth
compar ep growth rang ko issu press releas
may post decis maintain beverag africa
ccba stake highlight reclassif
expect impact organ revenu compar ep growth guidanc
said believ ccba organ growth profil slightli ko base
busi result estim bp neg impact top-line growth
ko also indic guidanc cash oper would increas
least least capit expenditur
would also increas
estim updat ccba consolid updat model reflect
consolid ccba busi ko financi statement
ep estim unchang post consolid higher
sale off-set lower margin oper profit line item
organ sale growth estim tick bp previous
reflect expect lower growth profil ccba due lower margin
profil ccba gm estim fall bp
oper margin estim fall bp
thought quarter
expect ep in-lin consensu
forecast unit case volum growth includ asia pacif
partial off-set north america organ sale growth forecast
concentr sale line unit case sale
expect y-o-i revenu growth compris organ sale
growth benefit ko costa acquisit partial off-set
headwind fx
forecast om contract bp y-o-i expect bp
y-o-i gm compress fx structur item bp declin sg
sale driven product off-set cycl fx gain
upgrad ko ow may detail ow thesi pleas see
note thing upgrad ow structur higher growth reflect
valuat video webcast replay slide deck
stronger price power peer coke price power increas
last year shift mix focu higher price slower growth
develop market last three year price/mix growth ahead
peer revers unfavor bp gap believ
ko greater price power sustain focu mix price
pack architectur well favor structur driver price
favor strategi tweak includ total beverag strategi believ
numer favor strategi tweak rel new ceo
includ cultur shift becom nimbl compani total beverag
focu allow penetr greater extent higher growth non-
attract valuat offer compel entri point trade ntm
price-to-earnings discount mega-cap peer pep/pg/cl nearli standard deviat
histor premium seem low given high visibl greater organ
sale ep growth potenti ko well higher return
posit stock reaction expect posit stock reaction earn
expect lower input cost inflat guidanc
current rais ep guidanc
assum reinvest commod upsid
input inflat believ report input cost inflat
sequenti improv pleas contact us
commod tracker histor r-squar relationship
report input cost inflat also expect favor revis input
cost inflat guidanc headwind
driven favor move pulp price input cost
lower visibl versu typic year given cycl favor
contract pulp tracker move favor ytd deflat
pulp basket lag quarter versu inflat begin
year provid initi input cost guidanc
potenti reinvest increas invest level prioriti new
ceo mike hsu medium term guidanc embed gross margin
expans excess oper margin expans given reinvest
believ reinvest need aggress address market share pressur
key countri categori combin believ favor pulp price
movement provid flexibl ep upsid reinvest
beyond worri substanti reinvest need beyond
bp jump sale
organ sale growth forecast average yoy organ sale
growth increas previous similar
average benefit price
mix augment volum growth net expect anoth
solid quarter organ sale growth given us western european
scanner data acceler sequenti comparison eas bp
sequenti flat organ sale growth vs segment model
organ sale growth person average consum
tissu average kc-profession average
acceler vs growth
driven price two-yr average us scanner sale growth improv
slightli us track channel scanner data
result impli organ sale growth north america consum
europ track channel scanner data sale
average average
average
rais estim rais ep estim cent higher
organ sale growth ep estim cent consensu
see upsid balanc year estim ahead
consensu high end current guidanc rang
thought quarter
ep estim cent consensu
forecast organ sale growth bp consensu vs flat
comparison expect organ sale growth person two-yr
average organ sale growth consum tissu two-yr average
organ sale growth kc-profession two-yr average
anticip oper margin increas bp y-o-i bp
consensu driven bp y-o-i gross margin expans bp
consensu forecast mr sg sale increas bp y-o-i
cycl bp y-o-i mr decreas base period
tightli manag expens sever input cost pressur
challeng top-line outlook continu project long-term organ revenu
growth in-lin recent downwardli revis guidanc
prior driven competit concern pg/privat label pressur
north america profit local compani pressur china also see
mute categori growth declin birth rate us/develop market
upsid guidanc see upsid guidanc post better
expect result decreas expect input cost inflat
guidanc detail profit build point oper profit growth
valuat reflect long-term fundament trade
price-to-earnings multipl view kmb price-to-earnings discount vs higher growth hpc peer
pg/cl/chd/clx discount vs pg/cl appropri consid
cautiou long-term organ sale growth/ ep outlook although see near-term
trade upsid lower input cost
million except ep
sale
modest posit stock reaction expect modestli posit stock
reaction cl improv sequenti organ sale growth model
vs easi comparison
also see potenti ep upsid undemand gross margin comparison
bp yoy price flow margin moder fx/commod
headwind partial off-set cl reinvest
sale growth lower modestli bp prior
weaker us scanner data easi comparison year ago period
neg impact brazil trucker strike worth bp cl
top-line growth averag basi model growth vs
also note us/european scanner data
remain mute believ untrack channel perform better
us scanner data remain mute higher price off-set lower volum
cl us scanner data sale growth y-o-i
improv vs growth cl
us price/mix growth acceler vs
volum improv vs
average basi cl us scanner data sale growth
european scanner data updat cl european scanner data sale
deceler slightli vs
average basi cl sale growth vs
in-lin
expect unchang ep guidanc gross margin guidanc end
believ cl reiter ep guidanc -msd y-o-i organ
sale growth guidanc also believ cl point lower end
prior bp gross margin guidanc
acquisit laboratoir filorga cosmtiqu skin busi juli
cl announc acquisit laboratoir filorga cosmtiqu filorga skin
busi filorga premium anti-ag skin care brand focus
primarili facial care origin found franc brand current
sold countri largest market franc itali spain
greater china filorga brand multi-channel distribut strategi across
pharmaci on-line specialti store travel retail acquisit expect
close cl indic impact ep acquisit
follow prior two small acquisit pca skin eltamd profession
skin care confirm cl aspir expand attract skin care categori
rais price target rais pt prior base
ep estim prior given higher stapl multipl particularli
thought quarter
ep estim cent consensu
forecast cl organ sale growth y-o-i volume/mix
price y-o-i comparison two-year averag basi model
growth vs organ sale growth
forecast driven latin america easi comparison
neg impact brazil trucker strike worth bp latin
america sale growth bp cl top-line growth africa/eurasia
hill pet nutrit north america lower prior
still scanner trend reflect faster untrack channel follow
europ asia organ sale growth
forecast oper margin bp y-o-i model bp
gross margin expans price benefit bp fund growth
bp partial off-set fx/commod headwind bp gross margin
expans off-set bp increas spend sale
greater invest behind busi sg sale
slower top-line growth histor trend expect organ sale
rang beyond cl msd histor trend low
end cl lt target believ cl organ sale growth emerg
market return histor level due heighten competit
local player competit environ well lower inflationari price
compar last year
diminish strateg still believ cl advantag vs peer
greater mix higher growth emerg market person care product
categori believ market attribut lower strateg halo
histor given weaken fundament compar histor trend note
knowledg potenti transact involv cl
level premium household product peer start look stretch
consid weaken fundament outlook cl diminish strateg
halo particularli believ cl price-to-earnings premium pg look high consid
greater top-line oper profit growth outlook pg
million except ep
sale
sale
posit reaction bar pg high post ytd stock price
out-performance still expect posit stock reaction earn
round organ sale growth like mind offici bit
conserv would surpris upsid expect
gross margin inflect albeit in-lin initi guidanc
organ sale growth forecast organ sale growth slightli
prior round result like mind vs
two-yr averag basi forecast
slightli
us scanner data trend remain strong look scanner data pg us trend
remain strong y-o-i us track channel sale growth
close importantli
averag basi pg us scanner trend acceler vs
also view forward growth outlook
solid given recent us scanner data strength accompani continu
yoy pullback promot spend bp yoy sale calendar
larg bp declin drive forward result
european scanner data deceler european trend deceler
y-o-i increas average vs
increas average increas average
gross margin inflect expect gross margin inflect pg y-o-
gross margin bp y-o-i vs flat bp y-o-i
robust price moder commodity/fx pressur
initi ep guidanc expect pg provid solid initi guidanc
includ expect organ top-line growth guidanc rang vs mse
consensu rang wide warn last
rang bracket ep consensu estim mse
expect solid organ growth margin expans partial off-set
higher tax rate model bp increas pg tax rate worth cent
bp y-o-i ep growth headwind cycl expect land sale gain
estim chang price target rais rais ep
reflect slightli higher organ top-line growth
modestli lower fx headwind howev ep tick cent
higher tax rate rais pt base
price-to-earnings prior reflect higher stapl multipl particularli
thought quarter
ep cent consensu estim rais
ep estim slightli higher organ top-line growth assumpt
reflect acceler averag trend us scanner data
forecast y-o-i pg organ sale growth slightli
prior prior year comparison driven volum
price mix two-yr averag basi forecast slightli
forecast oper margin expand bp y-o-i driven bp
y-o-i gross margin expans posit price cost save benefit partial
off-set commod freight/transport headwind albeit moder
also expect sg sale bp y-o-i driven cost save
overhead reduct well expect pg land sale expect
cent benefit ep
top-line momentum look sustain year subpar organ top-line
growth believ strategi tweak put place recent year begin
bear fruit acceler pg top-line growth back rang
us improv breadth perform reduc promot
intens give us confid market share momentum sustain
combin improv price outlook greater agil organiz
chang implement support top-line growth hpc peer see
near-term top-line slowdown difficult comparison
improv margin outlook follow nearli year gross margin declin
expect gm expans resum led improv price
realiz less oner commod headwind combin sizabl
cost-sav program worth annual profit see scope bp
annual margin expans turn hsd ep growth deliveri long-term
valuat look compel rel basi pg trade
ep discount hpc peer rel valuat look compel given higher
pg growth peer
million except ep
sale
posit stock reaction expect posit stock reaction strong
organ sale growth like stand well packag food peer
expect continu emerg market momentum solid price realiz
us
us scanner data updat us scanner data growth
y-o-i average basi
us scanner trend in-lin
us scanner data price/mix growth acceler
y-o-i average vs average
average volum growth improv y-o-i
average vs average average
solid organ sale growth forecast organ sale growth
vs averag basi model
organ sale growth vs
rais price target rais price target base
ep/ reflect higher estim higher stapl multipl
thought quarter
ep estim in-lin consensu
forecast y-o-i organ sale growth prior
y-o-i comparison comparison adjust
revers malwar incid year ago period y-o-i
organ sale growth forecast driven latin america cycl
neg impact brazil trucker strike worth bp latin america
sale bp total sale growth asia middl east africa
north america close us scanner data trend europ
forecast oper margin bp y-o-i driven bp
gross margin expans price benefit off-set commod headwind
also model bp increas total sg sale higher invest
behind busi
improv top-line forecast lt top-line growth close
market impli expect although slightli compani lt guidanc
see geographic/categori skew favor growth vs
peer believ manag increas focu top-line growth
pay drive top-line acceler lt vs last eight quarter
limit margin expans rel strong histori forecast limit
bp annual margin expans post product opportun
lower surfac mind given ineffici due
structur factor higher mix lower-margin intern market
cost burden us direct store deliveri believ bia reinvest
behind busi drive top-line growth
valuat look fair valuat price-to-earnings ev/ebitda
look fair larg respect premium food peer
fairli driven stronger growth prospect vs food peer compel
enough justifi ow
mute neg reaction expect profit/ep miss mse
consensu led continu us str weak cost pressur
believ consensu forecast in-lin bearish market
expect particularli given commentari call
optimist second half pessimist sinc call consensu
ep estim came still see potenti downsid
top-line growth forecast local currenc sale
year-ago comparison includ increas price/mix off-set
volum decreas us total revenu
forecast str y-o-i reflect weak us scanner data volum
trend prior close improv vs declin
expect us volum trend posit
impact shift albeit off-set poor us weather
forecast shipment y-o-i slightli deplet
cycl shipment bp deplet given
delay albani breweri go-liv peak summer sell season
regard us price/mix forecast increas
close
y-o-i average close average
improv vs declin average declin
average lose bp y-o-i volum share close
bp
outlook provid formal ebit/ep guidanc see
modest risk consensu estim despit expect miss
estim in-lin consensu given commentari earn call
full-year consensu estim ballpark term key line
item expect reiter prior guidanc includ plu
minu underli free cash flow msd underli cog per hectolit
lower price target lower price target
reflect weaker us scanner data trend pt dcf-base
thought quarter
ep estim consensu
forecast y-o-i local currenc sale decreas driven
increas price/mix off-set volum decreas forecast
headwind fx report sale y-o-i
forecast oper margin decreas bp y-o-i bp y-o-i
gross margin declin continu commodity/freight inflat top-line
de-lever off-set bp sg leverag sale moder
bp leverag bp leverag led
synergi realiz lower ad spend
weak fundament outlook growth challeng compani burden
heavi exposur us beer categori sale exacerb
unfavor posit outsiz leverag declin premium
economi segment repres us volum mix respect
backdrop forecast organ sale compound-annual-growth-rate
bottom hpc/beverag coverag univers
remain sidelin near term combin continu volum
challeng us commod cost pressur gross margin high debt
leverag like continu weigh sentiment clear catalyst
horizon fundament pressur reflect valuat remain ew
mute stock reaction expect in-lin result consist consensu
guidanc worri aggress pg laundri categori
potenti slow recent momentum categori
organ sale growth forecast organ sale growth
estim increas bp continu momentum us
scanner data bp guidanc us track channel
scanner data deceler versu
two-year averag momentum also deceler
histor regress
nielsen scanner data report result impli organ sale
growth consum domest segment sale slightli
forecast given histor gap narrow past two quarter
model consum organ sale growth two-yr average
basi flat organ sale growth specialti difficult us dairi
environ off-set undemand comparison
us laundri categori deceler strength liquid laundri categori
track channel sale mix dissip somewhat sale
increas modest versu
gain bp market share pg bp henkel bp
categori price increas
percent sale sold promot increas bp yoy driven
pg bp yoy decreas bp decreas pg
increas promot bp yoy versu bp yoy seem
disrupt prior strong market share gain dissip bp yoy
bp last quarter could portend less rational forward
price increas previous announc price increas earn
portfolio includ cat litter waterpik impact tariff bake
soda carpet deodor prewash addit part intern busi
bulk sodium bicarbon product spd divis indic
competitor gener follow price increas addit
portfolio alreadi announc price increas announc
addit price increas condom dri shampoo bring price
increas portfolio look increment updat
initi consum retail reaction price increas addit look
updat promot level us laundri rel expect
previous indic could gross margin upsid laundri
environ rational expect track channel
liquid laundri sold promot decreas bp well
bp increas categori pg bp yoy could portend
less rational forward price environ top linger risk henkel
reinvest although henkel increas spend seem drive
traction scanner data result date
thought quarter
ep estim line consensu guidanc
rais organ sale growth estim bp vs
comparison bp guidanc line consensu
us scanner data momentum remain solid albeit deceler intra-
comparison organ sale growth comparison flat
organ sale growth specialti product comparison histor gap
report result scanner data impli consum domest
result slightli forecast given gap narrow
anticip oper margin compress bp yoy bp
consensu driven bp gross margin contract bp consensu
comment expect slightli neg gross margin along
bp lower market sale line guidanc flat
sg sale easi comparison off-set flawless deal
solid top-line growth skew lower growth competit us market
limit lt growth although near-term us price acceler market
share gain drive solid growth expect drive fy upsid
valuat reason chd valuat ep yield
look reason premium peer consid solid organ sale
neg stock reaction expect neg stock reaction driven
disappoint initi guidanc ep growth estim
ep bp consensu
lower organ sale growth forecast organ sale growth
vs y-o-i comparison bp prior estim
reflect mute us scanner data sale growth estim bp
scanner data updat scanner data sale decreas
yr average weak trend similar average
average average
histor gap report organ sale growth bp
rang given faster growth non-track channel particularli club e-
commerc gap narrow past two quarter us
organ sale estim impli bp scanner report result
closer bp gap past quarter
initi ep guidanc telegraph anoth
algorithm year headwind increas competit threat trash
bag wipe well higher tax rate expect guid ep
rang midpoint near estim
consensu net ep growth estim
gross margin guidanc contrari market enthusiasm margin
recoveri lower resin price believ gross margin expand
mute bp consensu bp agre resin price
favor highlight lack price inflat commod
specialti chemic detail gross margin build emb bp gm
expans cost save consist histori bp price chang
price dissip given cycl price increas portfolio
last year bp favor input cost lower resin price
partial off-set commod inflat bp manufactur
logist similar bp average drag bp
forecast bp drag reinvest trade support
address competit issu trash bag wipe
competit threat trash bag wipe charcoal expect provid
competit updat three key categori competit structur
issu emerg trash bag increas price time
resin inflat dissip key competitor hefti step promot
gain market share sale declin improv
prior quarter market share loss remain sever lose
bp share slightli improv bp prior quarter wipe
call widen price gap competitor particularli rb lysol brand
increas promot intens histor market share loss follow
wider price gap indic expect increas trade invest
categori howev expect sequenti improv impact
weaker cold flu season wipe scanner data sale
improv yoy average declin
average yoy average expect updat
charcoal categori increas price revamp packag
introduc innov charcoal sale us track channel decreas
bp market share loss royal oak smaller competitor
natur charcoal product gain bp market share well
estim updat lower ep estim cent
reflect weaker scanner data organ sale estim decreas bp
bring estim midpoint
thought quarter
ep estim cent consensu
forecast organ sale growth prior year comparison
driven price/mix volum segment expect clean
price/mix aid price increas bleach part household
cleaner profession volum declin competit pressur
wipe household price/mix price increas cat litter trash bag
charcoal volum given continu pressur trash bag
charcoal lifestyl price/mix salad dress burt bee
price volum nutranext enter organ sale base
post organ sale growth y-o-i comparison
inflationari price
estim oper margin contract bp y-o-i model bp
yoy gross margin expans line consensu gross margin line
model bp increas advertis sale support
innov partial off-set bp sg leverag cycl nutranext
integr
limit organ sale growth potenti vs hpc skew low-growth
product categori high exposur competit us market along
specif challeng trash bags/wip charcoal limit lt top-line potenti
vs peer view
valuat high view valuat ev/ebitda
price-to-earnings standard deviat last year average vs hpc peer
high consid msd lt ep growth limit strateg potenti
million except ep
sell administr
sale
sale
sale
mute reaction expect mute stock reaction earn given
provid color expect weak profit last earn call
believ confid level potenti addit color impli
profit improv embed guidanc key driver
stock perform see result toward low end full-year
fx-neutral ep growth includ impact divestitur
like given mute us scanner data trend need reinvest
sever year reduct
us scanner data updat us scanner data growth deceler slightli
vs average basi us
scanner trend improv vs
price/mix growth remain solid y-o-i average vs
average average volum
growth remain weak y-o-i average vs
average average
organ sale growth forecast organ sale y-o-i
prior vs two-year
averag basi model organ sale growth vs
organ sale forecast driven growth amea y-o-i
multipro enter organ base north america y-o-i in-lin
scanner data trend partial off-set latin america difficult
comparison outsiz growth pringl parati europ
difficult comparison strong growth cereal pringl
lower ep estim lower ep estim cent
given mute us scanner data result
thought quarter
ep estim line consensu
forecast organ sale growth y-o-i y-o-i comparison
two-year averag basi model organ sale growth vs
y-o-i organ sale forecast driven
growth amea y-o-i north america y-o-i partial off-set
latin america europ
forecast oper margin bp y-o-i estim
driven bp y-o-i gross margin contract one month impact
multipro acquisit well impact increment cost relat on-
the-go packag format partial off-set revenu growth manag benefit
also model bp increas sg sale vs larg bp
decreas time sg spend kellogg indic would
revers partial off-set product project save overal
model oper profit ex-fx vs
organ top-line improv believ organ top-line growth
improv growth post vs flat prior two
year higher reinvest busi lt org sale forecast
low end guidanc includ futur
 limit exposur slow growth area struggl us packag
significantli lower profit growth outlook howev believ
modest top-line improv come cost significantli lower oper
profit outlook evidenc flat oper profit guidanc pre-
valuat still look stretch believ valuat
price-to-earnings pension adjust basi report ev/ebitda look
stretch mute profit growth poor convers
thought stock reaction believ stock reaction fiscal ep
mute given unfavor scanner data quarter alreadi reflect low
expect stock market focus pend
harri deal ep estim cent consensu driven lower
organ sale growth expect top-line forecast consensu
organ sale growth forecast y-o-i organ sale growth
comparison average vs trail ltm mute top-line
reflect challeng price competit environ off-set tailwind
time revers wet shave north america sun model
wet shave organ sale flat sun skin also model
organ sale feminin organ sale
harri deal may announc acquisit harri
compani expect close end calendar
worri carri high degre risk transform
acquisit harri ltm sale mix time
proceed larg cost-cut program look divest larg piec
heritag busi fem infant manag base
busi weak risk also heighten high pro-forma debt leverag
nearli ltm debt/ebitda ex synergi manag chang
harri team take manag us brand potenti turnaround
around heritag brand requir differ skill set
histor acumen grow harri busi still profit
said believ bring intern distribut platform harri
well scale d/technolog platform harri bring e-commerc
dtc direct-to-consum knowledg omni-channel expertis
manag team proven acumen develop harri brand
scanner data updat us track channel sale growth deceler
average vs average
average two-yr average wet shave scanner
data vs
two-yr average feminin scanner data vs
two-yr average sun care scanner
data vs flat
two-yr average european scanner data sale
vs
potenti risk sun highlight although raini spring like
impact sunscreen sale categori sale declin us scanner data
sun care declin lost bp market share
distribut tdp quarter us track channel
project fuel continu expect increment gross save
project fuel lead eventu gross save
end estim onetim pre-tax charg approxim
addit capit invest end
lower ep estim lower ep
reflect lower oper margin higher reinvest
thought quarter
expect fiscal ep cent consensu
forecast y-o-i organ sale prior year comparison
model wet shave organ sale flat sun skin
also model organ sale feminin organ sale
expect oper margin increas bp y-o-i driven bp
decreas gross margin unfavor product mix increas product
cost model total sg bp sale
bp anticip continu focu elimin facet spend
project fuel flat sg bp
combin organ heritag lsd harri
weak overal compani categori growth competit industri
environ harri gain share small base
high degre risk see risk high combin compani
transform acquisit harri ltm sale mix time
proceed larg cost-cut program look divest larg
piec heritag busi fem infant manag
base busi weak risk also heighten high pro-forma
debt leverag nearli ltm debt/ebitda ex synergi manag
chang harri team take manag us brand potenti
turnaround around heritag brand requir differ skill set
histor acumen grow harri busi still profit
valuat look fair trade pro-forma ev/ebitda
lower end hpc peer view valuat fair given high degre risk
million except ep
sale
balanc risk/reward view ep major catalyst newel stock
given expect mute organ sale growth quarter mse
unchang guidanc unlik catalyz chang
investor sentiment particularli market wait clariti surround
next ceo note cycl particularli weak organ sale
driven toy us liquid signific
inventori de-stock write offic superstor
organ sale growth trend forecast organ sale declin
mid-point guidanc flat declin headwind
toy us bankruptci dissip segment forecast organ
sale declin learn develop vs declin driven time
shift write shipment partial off-set babi sub-seg
improv bankruptci longer impact result declin
learn develop augment declin outdoor
live vs sequenti improv coleman trend posit
side forecast growth food applianc vs
ceo search june announc appoint cfo christoph
peterson interim ceo prior ceo mike polk retir end june
compani also state search perman ceo preced well
board posit announc extern hire perman
ceo upcom week look updat ceo search process
portfolio divestitur june announc sell unit
state play card compani uspc gener net sale
cartamundi group accord press sourc deal
expect close expect provid updat continu
portfolio divestitur program expect deliv tax
proce remain look increment color around time
divestitur updat use proce debt repay vs share
guidanc expect chang key line item guidanc
includ organ sale declin -lsd normal oper margin
improv bp normal ep oper cash flow
guidanc
lt margin expans opportun look increment color
surround lt margin opportun recal cagni point mid-
teen om target time bp opportun sale
partial off-set greater brand invest
fy ep estim unchang maintain ep estim
respect ebit estim current consensu
ep estim in-lin consensu
thought quarter
ep estim cent consensu
lower-end rang
forecast organ sale declin mid-point
flat guidanc growth estim learn develop
driven time shift write shipment estim
outdoor live off-set growth food applianc
anticip oper margin decreas bp y-o-i bp gross
margin declin driven higher cost inflat partial off-set bp lower
sg sale driven greater effici cost cut initi
slow new hire system consolid pull back bp y-o-i
margin contract forecast toward mid-point guidanc flat
bp
growth soften retail landscap remain challeng inventori de-
stock cost busi appear high
valuat warrant given lack visibl trade low end
peer time pro-forma ev/ebitda look fair consid
visibl around fundament top-line recoveri remain low potenti larg
cost save opportun off-set reinvest risk
mute stock reaction expect mute stock reaction result
expect weak result acquir busi batteri
auto care believ stock under-perform intra-quart alreadi price
weak believ confid abil stabil top-line
trend acquir busi improv legaci auto ebitda
key drive stock perform
solid sale increas average in-lin
average average
busi us scanner data trend remain weak albeit lost sale
shift higher-pr energ brand us track channel sale
batteri busi decreas average vs
average average
weak auto us scanner trend poor weather acquir auto
care us scanner data also weak poor weather well underli
busi weak pleas note signific portion busi sold
untrack channel us track channel sale decreas
yr average average similar
western europ scanner data european scanner data sale includ
acquir batteri busi ex-varta increas y-o-i
average average
average
guidanc believ reiter ep guidanc
organ sale growth guidanc point low-end
total sale guidanc reflect weaker trend acquir
busi howev note visibl low given import untrack
channel expect distribution/shelf space gain
thought quarter
expect ep prior line
model y-o-i organ sale growth driven growth
america reduc acquisit contribut
estim bp reflect weak us track channel trend
acquir batteri auto care busi
forecast oper margin bp y-o-i lower gross
margin acquir busi model gm bp y-o-i off-set
lower level busi lower sg forecast sg
sale bp y-o-i
deal integr risk high debt leverag believ deal integr risk
high post announc acquisit batteri busi acquisit
auto care given simultan integr two busi
differ categori struggl albeit buyer
similar systems/etc addit concern high pro-forma debt
leverag net debt/ebitda
improv fundament batteri categori forecast long-term
revenu growth outlook base vs hpc peer rang
improv batteri categori evidenc recent updat lt
outlook categori growth flat slightli posit vs flat
lsd prior also believ price environ improv batteri
categori post batteri deal
valuat start look attract trade
ebitda forecast pro forma basi fulli synerg low end lower
qualiti hpc peer start look attract
howev remain ew given deal integr risk soft near-term trend
acquir busi high debt leverag
schedul report date wednesday august estimate ms estim in-lin
expect in-lin quarter expect deliv in-lin quarter
expect benefit cloverhil acquisit compani
leverag expand breakfast platform expand new channel
club top-line growth also driven list price increas
optim price pack architectur recent breakfast innov hostess
danish jumbo donett improv merchandis moder yoy
input cost inflat sugar corrug measur channel data point
strengthen sale basi
acceler rel yoy sale growth stronger volum
yoy off-set modest price/mix declin yoy sale within mass channel
shown signific improv turn posit growth yoy end
top-line benefit price increas implement multi-facet price
increas across portfolio late flow quarter
howev measur channel data point neg price/mix quarter
appear inconsist compani list price increas
cloverhil integr transform look updat
cloverhil integr outlook profit ebitda growth
respect initi target mm ebitda
success new product launch pipelin look updat
donett upcom innov pipelin
updat strateg initi outlin number strateg initi last
quarter includ open new offic chicago move distribut
thought quarter
ep estim in-lin consensu
forecast net sale growth top-line estim vs
consensu reflect growth sbg/other busi
mm contribut cloverhil
forecast gross margin increas bp y-o-i model bp
yoy gm increas high freight cost cloverhil headwind
overal model ebit mm vs consensu mm ebit
estim reflect higher cog expens due sustain freight inflat
market support platform innov
ep estim consensu
forecast net sale growth top-line estim in-lin
consensu reflect growth sbg/other busi
mm contribut cloverhil
forecast gross margin increas bp y-o-i model
bp y-o-i gm increas benefit product program
lap elev input cost inflat
overal model ebit mm vs consensu mm
advantag growth profil face risk slow categori share trend
expect deliv lsd mid-term organ sale compound-annual-growth-rate msd
outlook given slow categori trend weaker share momentum
compani continu grow packag food peer
margin expans limit potenti risk neg mix gross
ebitda margin alreadi benefit aggress post-bankruptci
restructur shift warehous distribut leav limit potenti
oper leverag potenti downsid neg mix
potenti accret mitig leverag snack focu
like lever valu creation given compani focu acquisit adjac
categori see potenti hsd ep accret view prospect
limit high leverag competit landscap
premium packag food peer warrant rais price target
bear case bull case due improv
top-line momentum pt base price-to-earnings reflect
premium food peer given rel stronger top line ep growth
ev/ebitda basi appli multipl in-lin peer given twnk
rel higher leverag see balanc risk reward downsid
bear case upsid bull case
million except ep
sale
mute stock reaction expect mute stock reaction expect solid
result given high expect high valuat level continu
worri long-term legaci keurig trend could slow see recent april downgrad
detail
us scanner data slow sequenti poor weather total compani us
track channel sale growth y-o-i vs
averag basi us scanner data sale
close categori basi scanner
data sale growth carbon soft drink csd y-o-i
strong price/mix growth partial off-set volum
us singl serv coffe volum growth deceler volum growth us
single-serv coffe categori track channel deceler vs
although believ untrack channel
acceler averag basi volum growth vs
brewer innov front look
color k-duo newli announc brewer function brew larg
cup coffe tradit drip system addit single-serv cup
k-cup pod avail purchas retail summer
price front us singl serv coffe price/mix vs
howev flag low visibl kgm side
driven lack price detail contract coffe partner long-
term contract partner scanner data trend reflect report
expect unchang guidanc believ reiter ep
guidanc rang rang top-line growth
thought quarter
expect ep in-lin consensu
forecast organ sale y-o-i growth driven organ sale
growth latin america beverag organ sale growth beverag
concentr packag beverag coffe system
believ time shift bp benefit
forecast om expand bp y-o-i expect gm
bp y-o-i solid price csd partial off-set commod cost
increas model bp decreas sg sale driven cost
synergi well legaci kgm/dp product save
downgrad uw april believ market overestim
kdp lt growth potenti limit revenu growth ebitda margin
expans synergy-rel growth dissip next coupl year
risk base slow us coffe pod scanner data result recent
alphawis survey consum also believ market
appropri factor high risk level larg deal recent dp
high debt leverag aggress assumpt full drop-through cost synergi
bottom line top base busi growth given opaqu coffe
busi model detail pleas see downgrad note downgrad uw
caffein stock could lose buzz alphawis note
believ single-serv coffe penetr matur forecast household
penetr growth single-serv brewer slow msd vs market
expect hsd growth support find alphawis survey
includ us single-serv penetr alreadi high base
survey non-own like purchas single-serv
brewer awar keurig system alreadi high
risk-reward neg skew view risk/reward neg
downsid risk/reward skew bull case stock upsid signific
bear case downsid base dcf analysi high level assum
ebitda multipl legaci dp busi discount ko/pep
multipl synergi market price impli ebitda
multipl keurig busi look high view focu
ev/ebitda multipl price-to-earnings given high debt leverag
mute posit stock reaction us scanner data trend import
expect mute posit stock reaction earn expect
sales/ep beat aid reign pipelin fill partial off-set gross margin miss
larg due bogo buy-on get-on promot reign howev
see bi-weekli scanner data result us import stock
trajectori given volatil retail sale trend reign innov
us growth driven reign pipelin fill untrack channel model us
sale growth well us scanner
data trend reflect expect benefit reign pipelin fill bp
faster growth untrack channel indic june sharehold
meet averag basi model growth close
us scanner data market share updat us track channel retail
sale increas y-o-i includ reign average
well average growth
average average exclud contribut reign
bp base busi well
impli high level cannib reign us market share
bp y-o-i us track channel data vs bp
larg deceler vs bp bp bp bang
gain bp y-o-i market share energi drink categori vs
bp howev bang market share stall sequenti
end vs end also note growth trend report
data servic provid run nielsen trend
growth y-o-i average
average average
sale growth ex-fx report basi vs
yr averag basi model intern sale growth
juli monthli sale commentari expect juli preliminari gross sale mid-
to-high teen rang aid continu reign pipelin fill fdm channel
consid difficult comparison juli gross sale y-o-i
ex-fx addit competit us environ
lost arbitr ko juli ko announc
arbitr tribun american arbitr associ decid sale
allow term contract ko
see press releas decis surpris except
market rule ko continu sell distribut
market alreadi launch spain hungari
ko also free launch product addit market global believ ko
launch addit market europ balanc
potenti us launch long-term opportun
rais price target rais pt base
price-to-earnings reflect higher stapl multipl
thought quarter
ep estim cent consensu prior
reflect weaker gross margin assumpt base commentari
forecast y-o-i net sale growth ex-fx bp
consensu us y-o-i ex-fx fx
headwind total compani sale growth averag basi ex-fx
model growth close call may
mention total compani april gross sale y-o-i ex-fx
benefit addit sell day month make april fx neutral
revenu growth like mid-teen also cycl difficult comparison
april
forecast oper margin decreas bp y-o-i model bp
y-o-i gross margin contract prior flat estim reflect
impact bogo buy-on get-on promot reign neg countri
product mix partial off-set us price increas favor
commod model bp y-o-i decreas oper expens
sale driven bp decreas sell distribut expens
robust top-line growth forecast hsd lt revenu compound-annual-growth-rate msd us
ldd intern favor demograph trend drive categori growth
strong market share perform
competit ramp bang us success along launch coca cola-
brand energi product europ competit risk
note ccep plan releas result august ccep releas full
 result top-line result consist mani
modest neg stock reaction expect modest neg stock reaction
ccep result given slight expect ep miss margin vs consensu
expect solid top-line result believ market look ahead
difficult comparison organ sale comparison vs
recent downgrad ccep equal-weight overweight prior stock
out-performance see
innov updat partial offset neg describ believ
ccep sound bullish innov front particularli expans
territori post test-launch spain ko/ccep
arbitr allow expand
countri launch costa rtd coffe product uk addit
signatur mixer new diet flavor diet twist
solid organ sale growth difficult comparison horizon
forecast strong organ sale growth albeit prior
organ sale growth ccep alreadi report organ sale
growth howev remain concern difficult comparison
organ sale comparison vs ccep cycl
last summer favor weather western europ issu uk
enabl ccep gain signific market share less issu
competitor well favor impact world
proxi includ monster sale spain germani
franc uk increas y-o-i two-year averag
growth two-year averag
two-year averag forecast organ sale growth
base histor relationship report scanner data
organ sale growth consid report organ
thought quarter
ep estim cent consensu
forecast organ sale growth previou
comparison y-o-i organ sale growth base
histor relationship report scanner data trend
model oper margin flat y-o-i driven bp gross margin
contract commod headwind partial off-set price/mix benefit
estim gross margin contract off-set model bp reduct
sg sale larg expect cost synergi realiz
german/spanish bottler acquisit worth bp note forecast ccep
synergi realiz end estim cumul save
high end ccep target
recent downgrad ccep ew ow june believ ccep
valuat appropri reflect improv fundament outlook post
strong stock run sinc begin outperform peer
nearli point detail pleas see note full bottl downgrad
ew improv fundament price
lt top-line lsd rang believ ccep lt top-line outlook lower vs
cpg peer given high csd-skew volum exposur
slower growth western europ health/wel concern limit csd
categori growth howev believ improv lsd lt growth forecast
reason ccep consid favor mix shift toward higher growth
nartd categori particularli energi drink ration price environ
margin expans moder synergi model bp margin
expans per year post driven price/mix realiz moder vs
annual margin expans bp driven synergi
realiz german/spanish merger
valuat appropri reflect improv fundament outlook believ
ccep valuat price-to-earnings ev/ebitda price
improv fundament solid price/mix outlook favor mix shift
eur million except ep
sale
posit stock reaction conserv guidanc head despit
best scanner data trend nearli two year expect
handili beat consensu revenu estim handili posit revis fiscal
rebound us track channel trend track channel sale
increas yoy average average
signific improv declin average
distribut track channel measur y-o-i chang tdp grew
y-o-i follow declin
y-o-i increas confid forward outlook
growth outlook outsid us track channel also look sale
growth updat specialti channel includ updat direct-
to-consum intern market
tariff risk given oper outsourc manufactur model
major sourc china look updat commentari
around tariff risk includ headwind cog potenti offset
pursu particularli cosmet recent name list categori
incur tariff previous indic expect off-set tariff impact
occur combin fx benefit assum cog
import china currenc move hsd ep benefit vendor
concess select price action commun
rais estim rais revenu estim
ep estim due favor scanner
data rebound believ indic guidanc far conserv
revenu ep estim consensu
respect fy revenu ep estim
rais price rais price target
acceler y-o-i scanner trend ep estim goe
cent higher top-line estim
thought quarter
ep estim cent consensu estim
forecast organ sale growth vs
comparison growth ex retail store closur rebound scanner data
forecast oper margin contract bp y-o-i driven primarili
larg sg increas bp y-o-i greater brand invest
advertis grow sale well bp gross margin
contract given close retail store
top-line momentum build recent us scanner data improv
driven rebound volum growth due improv distribut veloc
trend highlight elf s/consensu estim declin revenu
way conserv
valuat look reason trade ev/ebitda includ stock
compens expens time exclud stock compens expens
look fair given anticip above-guid top-line rebound
return msd top-line growth long-term mind
mute stock reaction stock out-performance ytd expect
mute stock reaction el expect above-guid result in-lin
guidanc model organ sale growth el
organ sale growth forecast el organ growth prior
high end el guidanc two-yr averag
basi model organ growth growth
growth
china key debat stock remain sustain growth china
fuel strong result asia pacif organ growth
model strength segment continu albeit slow sequenti basi
y-o-i average vs y-o-i average
growth average
ep expect el guid fx neutral ep growth
bridg consensu estim ex fx consensu ep growth
fx impact high end lt org sale rang although
expect el eventu beat ep guidanc typic conservat
thought quarter
expect ep cent consensu el
forecast local currenc sale growth comparison
segment forecast america post local currenc growth vs
comparison emea vs comparison asia pacif
forecast oper margin contract bp y-o-i vs bp
comparison driven bp y-o-i gross margin contract off-set
bp decreas sg expens sale underli basi exclud
estim bp headwind new account standard forecast
oper margin roughli flat y-o-i
robust organ sale growth underli organ sale growth re-acceler
ldd rang well cpg peer lsd rang growth
gap widen recent quarter view el top-line out-performance sustain
long term albeit lesser magnitud strong prestig beauti categori growth
continu high growth area travel retail e-commerc el
disproportion exposur increas mix el busi rapidli
expand emerg market china us specialti channel
ev/ebitda valuat premium vs cpg peer low given much higher
topline/ep growth potenti long-term basi
million except ep
sale
interest incom
provis incom tax
net incom non-controlling
expect mute reaction result expect fiscal unev
guidanc paramet alreadi place earli juli
organ sale growth forecast currenc neutral sale declin
y-o-i vs underli declin divis
forecast growth luxuri vs growth profession
model declin vs declin profession continu
experi repercuss suppli chain headwind loss share
salon consum beauti model declin line
scanner updat us track channel data track total
compani sale sale growth average
vs average average
weak quarter y-o-i vs prior quarter
europ scanner sale deceler
average vs y-o-i average declin
outlook updat juli analyst updat issu financi target
focu restor profit de-lever stretch balanc
sheet enabl step commerci invest plan
address number histor concern stock includ
step plan p/r invest believ need
reinvigor sale princip consum beauti divis sale
difficulti low visibl turn around busi mind
underscor lt revenu growth guidanc continu believ
brand portfolio need increment invest visibl still low
around execut plans/high spend enough consum beauti
maintain share also point under-expos high growth
key lt concern us
thought quarter
ep estim in-lin consensu
forecast yoy currenc neutral sale declin driven
growth luxuri declin consum beauti declin
forecast oper margin increas bp y-o-i driven bp
gross margin expans driven price mix sg bp
sale led cost synergi net model y-o-i increas oper
mute top-line growth outlook view point behind new
manag team turnaround plan credibl visibl low
maintain market share given uncertainti around payoff higher spend
competit industri execut risk skew within high growth beauti
segment lower growth geographi channel retail
valuat look fair reflect earn visibl high leverag
pro forma ebitda ep trade valuat
discount hpc compani attract beauti peer believ
low earn visibl high net debt/ltm ebitda leverag
valuat methodolog risk
pt forecast organ sale growth go forward
hpc peer led improv us result build market share momentum better
price realiz continu cost save support bp om expansion/yr
drive hsd ep growth appli multipl ep slight
premium pg average given acceler fundament
share vacil currenc commod volatil
pt organ sale growth rebound oper
profit margin expand bp driven commod cost fx cost
save price benefit valuat ep slightli
histor averag ntm price-to-earnings
upsid risk includ lower expect commod cost higher birth rate drive
improv categori growth improv market share trend greater price realiz
downsid risk includ greater expect commod pressur price promot
realiz cost-cut downsid strengthen usd
pt forecast organ top-line growth beyond
appli price-to-earnings multipl ev/ebitda line
multipl appli pg given strateg potenti cl despit lower top-line
upsid risk stronger price greater market share payback ad spend
consolid potenti increas
downsid risk weaker price market share loss local player
categori growth slowdown stronger usd higher commod cost strateg
pt local currenc sale growth challeng weak macro
specif execut issu price-to-earnings standard deviat averag
last year
risk includ fx sale intern market materi
strengthening/weaken dollar signific impact
pt organ sale growth rebound om
bp cost save volum leverag flat reinvest
valuat expand ev/ebitda price-to-earnings plu hsd strateg
premium price-to-earnings all-in histor average ntm price-to-earnings
premium food peer given superior fundament pt support dcf
hsd strateg premium expect market assign
downsid risk volum recoveri lower price weaker price due lower
inflat em volum pressur categori weaker margin expans
higher reinvest dissip strateg potenti
upsid risk greater strateg potenti rebound volume/market share
pt forecast organ top-lin growth organ
price-to-earnings ccep histor price-to-earnings reflect improv fundament
upsid risk ccep complet accret acquisit new territori margin upsid
lower expect commod cost higher contribut innov
higher volum growth non-csd brand favor weather drive higher
downsid risk volum pressur health well concern sugar tax
potenti hard brexit unfavor fx movement higher expect commod
cost inflat unfavor weather weaker macro condit western europ
pt forecast organ top-line growth ep growth
beyond appli price-to-earnings multipl base case ep driven strong
price power posit strategi chang new ceo
health well pressur lower expect product soda tax
pt organ sale growth driven solid snack growth
om expand bp annual post reinvest cost save assum
price-to-earnings cpg peer reflect higher top-line growth visibl
risk includ lower expect return reinvest
russia/mexico/china volatil commod cost fx volatil lower expect
cost save restructur acceler competit intens beverag
soda tax macro and/or health-rel top-line weak
pt organ sale growth rang realiz full
synergi reach ebit margin appli
price-to-earnings ev/ebitda discount back cost equiti support
base case dcf analysi assum sales/nopat compound-annual-growth-rate wacc
downsid risk includ deal integr risk downsid synergi target lower price
realiz csd loss alli brand slower growth single-serv brewer
household penetr unlik potenti loss distribut ko/pep
pt e-commerc china travel retail drive strong organ revenu growth
five-year compound-annual-growth-rate cost-cut top-line leverag drive annual underli margin
expans bps/year appli ebitda multipl
risk includ china result slow tariff/boycott risk ad claim risk categori growth
deceler macro condit worsen market share loss competit price
pt organ top-line growth stabil back rang
declin moder us/canada bp margin expans larg driven cost
termin growth rate well npv tax relat benefit
risk includ us beer industri volum trend price environ cost-cut
upside/downsid commod tax law chang fx macro risk
pt organ sale growth rebound vs flat
oper margin contract bp flat cost
pressur reinvest valuat remain ev/ebitda impli
ep rebound near-term top-line growth partial offset weaker profit
upsid risk includ higher-than-expect us snack growth reinvest dsd
save stabil us cereal busi innov higher ad spend
higher margin expans greater cost save moder commod
downsid risk includ volum pressur consum shift healthier food option
price pressur us sale retail friction weaker margin
expans higher reinvest
pt forecast lt organ top line growth bp averag
margin expans expect valuat ep one standard deviat
averag reflect competit risk portfolio
risk includ top-line margin upsid improv price better expect
volum declin commod cost consolid potenti cost-cut
pt deliv average org sale growth slightli
long-term target appli price-to-earnings base case ep
standard deviat last averag strong organ
 product higher expect potenti accret acquisit
downsid risk includ competit price us promot intens key
categori ramp us volum downsid privat label share gain increment
commod inflat execut risk
pt follow expect ebitda declin model
stabil trend start ebitda compound-annual-growth-rate growth outsid
north america mostli off-set continu weak us/canada given mute
end market growth high competit intens dcf input
revenue/ebitda compound-annual-growth-rate post exit margin wacc tgr
risk includ us food industri volum trend price environ increment
cost-cut upside/downsid commod strateg potenti sector rotat
pt deliv lsd organ sale growth follow expect
lsd declin cost save drive om expans
appli ebitda in-lin secularli challeng name epc/tap
commod cost tariff risk fx
pt forecast lsd organ sale growth legaci l-msd
ebitda growth ex fx realiz midpoint synergi target appli
ev/ebitda multipl fulli synerg ebitda reflect deal
integr risk high debt leverag
risk includ deterior batteri categori volum greater/low competit
intens lead less/mor price realiz currenc commod cost risk
share gain higher/low expect deal integr risk around
batteri auto care busi deal
pt base price-to-earnings reflect premium packag
food peer given rel stronger top line ep growth ev/ebitda
basi appli multipl in-lin peer given twnk rel higher
risk thesi deviat categori growth rel current outlook
market share eros meaning contribut growth new product
innov whitespac higher oper leverag
pt heritag organ sale oper margin
bp forecast light slow harri busi
recent trend appli ev/ebitda multipl
given weak organ sale growth potenti due sluggish categori trend highli
competit categori well heighten risk
upsid risk upsid project fuel cost save target higher contribut
product innov wet shave sun skin feminin declin
moder shelf space loss market attribut increas
strateg potenti success deal execut harri
downsid risk save execut risk higher expect fx commod
headwind organ sale growth deceler higher price pressur wet
shave higher market share pressur product risk acquisit
pt deliv improv top-line growth post
rebound us trend strong growth e-commerc int market om fall
greater reinvest appli
upsid risk strateg risk given lt expans potenti greater expect
distribut expans success expans skin care
downsid risk competit risk custom concentr risk sourc risk china
cost volatil suppli chain hiccup around tariff higher debt leverag
pt deliv us revenu growth int revenu growth
valuat expand price-to-earnings premium high growth cpg peer given
much higher long-term top-line ep growth potenti well higher
upsid risk drop plan launch energi drink product strateg potenti
increas price drive margin higher contribut innov includ reign
higher intern sale growth market share gain
downsid risk increas competit bang legal/regulatori risk
lower gross margin product mix/geograph mix higher commod cost us
sale volatil intern margin weaker forecast
pt organ top-line growth remain mute rang pressur
consum beauti off-set steadi lsd growth luxury/profession synergy-
led margin progress drive ebit margin turn ebit compound-annual-growth-rate
dcf input wacc tgr exit multipl
risk includ synergy/cost save realiz suppli chain risk shelf space loss
consum beauti licens chang consum demand/macro risk
